SPN-817 not checked
Supernus Pharmaceuticals, Inc. · BIS-001ER
FollowEvery change as it happens, and a Monday email
Trials
4 active
4 in total · 2 in the EU
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “BIS-001 ER is an extended release formulation of the nutritional supplement Huperzine A.”In the company’s words, NCT03474770 on ClinicalTrials.gov
- Tested for
- Focal Onset Seizures (2 trials), Epilepsy, Seizures, Epileptic, Focal Impaired Awareness Seizures
- Main trialPhase 2
- “This is a Phase 2 double-blind, randomized, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy, safety, and tolerability of SPN-817 in adults with focal onset seizures.”In the company’s words, NCT06798896 on ClinicalTrials.gov
- Other names
- BIS-001ER · Huperzine A ER
Other drugs for Focal Onset Seizures
- BHV-7000Biohaven · Phase 2/3
- ElsunersenPraxis Precision Medicines · Phase 3
- LP352Longboard Pharmaceuticals · Phase 3
- EverolimusNovartis Pharmaceuticals · Phase 3
- CarisbamateSK Life Science, Inc. · Phase 3
- Clemizole HClEpygenix · Phase 3
Coming up4
- 30 DecPhase 1/2 trial completes · ClinicalTrials.gov
- Aug 2027Phase 2 trial completes · ClinicalTrials.gov
- 31 Dec 2027Phase 2 trial completes · ClinicalTrials.gov
- 31 Dec 2027Phase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials4
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Recruiting | Aug 2027 | RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures | |
| Phase 2Enrolling by invitation | 31 Dec 2027 | SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures | |
| Phase 2Recruiting | 31 Dec 2027 | Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy | |
| Phase 1/2Active, not recruiting | 30 Dec 2026 | BIS-001-ER for the Treatment of Adult Focal Impaired Awareness Seizures |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026